[Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D009202:Cardiomyopathies / Q000188:drug therapy; D002395:Catecholamines / Q000097:blood*; D003327:Coronary Disease / Q000188:drug therapy; D004298:Dopamine / Q000097:blood; D004837:Epinephrine / Q000097:blood; D006331:Heart Diseases / Q000188:drug therapy; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000494:pharmacology* / Q000627:therapeutic use; D009638:Norepinephrine / Q000097:blood; D005082:Physical Exertion; D011224:Prazosin / Q000494:pharmacology* / Q000627:therapeutic use; D011799:Quinazolines / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D002395:Catecholamines; D011799:Quinazolines; D005996:Nitroglycerin; D004298:Dopamine; D009638:Norepinephrine; D011224:Prazosin; D004837:Epinephrine
Hämodynamik und Katecholaminstoffwechsel unter einer Vasodilatatorentherapie der chronischen Linksinsuffizienz.